Trial Profile
Phase 3 Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Pilot Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Dec 2014
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 09 Dec 2014 New trial record